Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg Sells 65,236 Shares

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 65,236 shares of Outset Medical stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $0.80, for a total transaction of $52,188.80. Following the sale, the chief executive officer now owns 895,580 shares of the company’s stock, valued at approximately $716,464. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Leslie Trigg also recently made the following trade(s):

• On Monday, January 13th, Leslie Trigg sold 33,227 shares of Outset Medical stock. The shares were sold at an average price of $0.81, for a total transaction of $26,913.87.
• On Tuesday, January 7th, Leslie Trigg sold 10,227 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total transaction of $13,192.83.
• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total value of $4,516.00.

Outset Medical Trading Down 3.3 %

Shares of OM stock traded down $0.03 on Wednesday, hitting $0.78. 951,459 shares of the company’s stock traded hands, compared to its average volume of 2,184,304. The stock has a market capitalization of $40.98 million, a price-to-earnings ratio of -0.28 and a beta of 2.05. The company’s fifty day simple moving average is $1.01 and its 200 day simple moving average is $1.28. Outset Medical, Inc. has a one year low of $0.44 and a one year high of $5.22. The company has a debt-to-equity ratio of 4.12, a quick ratio of 5.04 and a current ratio of 6.49.

Institutional Investors Weigh In On Outset Medical

Hedge funds and other institutional investors have recently modified their holdings of the stock. National Bank of Canada FI boosted its position in Outset Medical by 79.2% during the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after buying an additional 23,164 shares during the period. Huntington National Bank lifted its holdings in Outset Medical by 46.2% in the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock worth $43,000 after buying an additional 20,000 shares during the period. GSA Capital Partners LLP increased its stake in shares of Outset Medical by 924.7% during the third quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock valued at $753,000 after buying an additional 1,003,135 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Outset Medical during the second quarter valued at approximately $259,000. Finally, Point72 Asset Management L.P. purchased a new stake in Outset Medical in the second quarter worth $827,000.

Analysts Set New Price Targets

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $3.00 price objective on shares of Outset Medical in a research report on Tuesday, January 7th.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.